Stephan Kirschbaum
Corporate Officer/Principal at DOTTIKON ES HOLDING AG
Net worth: 1 M $ as of 30/04/2024
Stephan Kirschbaum active positions
Companies | Position | Start | End |
---|---|---|---|
DOTTIKON ES HOLDING AG | Corporate Officer/Principal | 01/01/2009 | - |
Dottikon Es America, Inc. | Chief Executive Officer | - | - |
Chairman | - | - | |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Corporate Officer/Principal | - | - |
Career history of Stephan Kirschbaum
Former positions of Stephan Kirschbaum
Companies | Position | Start | End |
---|---|---|---|
UBS | Corporate Officer/Principal | 01/01/2005 | 01/01/2009 |
Mckinsey & Co., Inc. (Germany) | Corporate Officer/Principal | 01/01/1999 | 01/01/2005 |
University of California, Santa Barbara | Chief Tech/Sci/R&D Officer | 01/01/1997 | 01/01/1999 |
Training of Stephan Kirschbaum
University of Karlsruhe | Doctorate Degree |
Statistics
International
Switzerland | 5 |
Germany | 3 |
United States | 2 |
Operational
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Consumer Services | 3 |
Finance | 2 |
Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
DOTTIKON ES HOLDING AG | Process Industries |
Private companies | 4 |
---|---|
UBS AG
UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Dottikon Es America, Inc. | |
Mckinsey & Co., Inc. (Germany) | |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Stephan Kirschbaum
- Experience